Freeline Therapeutics
Based in London, Freeline is a privately-held clinical-stage biotechnology company focused on AAV based gene therapy targeting the liver.
The firm says it has: "a vision is to create better lives for people suffering from chronic systemic diseases using the potential of gene therapy as a one-time curative treatment." Freeline is headquartered in the UK and has operations in Germany and the USA.
Latest Freeline Therapeutics News & Features
24 November 2023
22 November 2023
Today's issue
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze